Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Chronic non bacterial osteitis- a multicentre study.

Bhat CS, Anderson C, Harbinson A, McCann LJ, Roderick M, Finn A, Davidson JE, Ramanan AV.

Pediatr Rheumatol Online J. 2018 Nov 22;16(1):74. doi: 10.1186/s12969-018-0290-5.

2.

Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom.

Kearsley-Fleet L, Sampath S, McCann LJ, Baildam E, Beresford MW, Davies R, De Cock D, Foster HE, Southwood TR, Thomson W, Hyrich KL.

Rheumatology (Oxford). 2019 Feb 1;58(2):331-335. doi: 10.1093/rheumatology/key306.

3.

The Vasculopathy of Juvenile Dermatomyositis.

Papadopoulou C, McCann LJ.

Front Pediatr. 2018 Oct 9;6:284. doi: 10.3389/fped.2018.00284. eCollection 2018. Review.

4.

Juvenile dermatomyositis: Latest advances.

Wu Q, Wedderburn LR, McCann LJ.

Best Pract Res Clin Rheumatol. 2017 Aug;31(4):535-557. doi: 10.1016/j.berh.2017.12.003. Epub 2018 Jan 10. Review.

PMID:
29773272
5.

Response to: 'Antisynthetase syndrome or what else? Different perspectives indicate the need for new classification criteria' by Cavagna et al.

Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Jordan P, Benveniste O, Danieli MG, Dankó K, Phuong Thuy NT, Vázquez-Del Mercado M, Andersson H, Paepe B, De Bleecker JL, Maurer B, McCann LJ, Pipitone N, McHugh N, Betteridge Z, New P, Cooper RG, Ollier WE, Lamb JA, Krogh NS, Lundberg IE, Chinoy H; all EuroMyositis contributors.

Ann Rheum Dis. 2018 Aug;77(8):e51. doi: 10.1136/annrheumdis-2017-212382. Epub 2017 Dec 19. No abstract available.

PMID:
29259048
6.

Development of a consensus core dataset in juvenile dermatomyositis for clinical use to inform research.

McCann LJ, Pilkington CA, Huber AM, Ravelli A, Appelbe D, Kirkham JJ, Williamson PR, Aggarwal A, Christopher-Stine L, Constantin T, Feldman BM, Lundberg I, Maillard S, Mathiesen P, Murphy R, Pachman LM, Reed AM, Rider LG, van Royen-Kerkof A, Russo R, Spinty S, Wedderburn LR, Beresford MW.

Ann Rheum Dis. 2018 Feb;77(2):241-250. doi: 10.1136/annrheumdis-2017-212141. Epub 2017 Oct 30.

7.

Tocilizumab as a potential therapeutic option for children with severe, refractory juvenile localized scleroderma.

Lythgoe H, Baildam E, Beresford MW, Cleary G, McCann LJ, Pain CE.

Rheumatology (Oxford). 2018 Feb 1;57(2):398-401. doi: 10.1093/rheumatology/kex382. No abstract available.

PMID:
29077971
8.

The EuroMyositis registry: an international collaborative tool to facilitate myositis research.

Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Oakley P, Benveniste O, Danieli MG, Danko K, Thuy NTP, Vazquez-Del Mercado M, Andersson H, De Paepe B, deBleecker JL, Maurer B, McCann LJ, Pipitone N, McHugh N, Betteridge ZE, New P, Cooper RG, Ollier WE, Lamb JA, Krogh NS, Lundberg IE, Chinoy H; all EuroMyositis contributors.

Ann Rheum Dis. 2018 Jan;77(1):30-39. doi: 10.1136/annrheumdis-2017-211868. Epub 2017 Aug 30.

9.

Consensus-based recommendations for the management of juvenile dermatomyositis.

Bellutti Enders F, Bader-Meunier B, Baildam E, Constantin T, Dolezalova P, Feldman BM, Lahdenne P, Magnusson B, Nistala K, Ozen S, Pilkington C, Ravelli A, Russo R, Uziel Y, van Brussel M, van der Net J, Vastert S, Wedderburn LR, Wulffraat N, McCann LJ, van Royen-Kerkhof A.

Ann Rheum Dis. 2017 Feb;76(2):329-340. doi: 10.1136/annrheumdis-2016-209247. Epub 2016 Aug 11. Review.

10.

A Practical Approach to Juvenile Dermatomyositis and Juvenile Scleroderma.

McCann LJ, Pain CE.

Indian J Pediatr. 2016 Feb;83(2):163-71. Review.

PMID:
26489640
11.

Co-existence of juvenile-onset systemic lupus erythematosus and juvenile myasthenia gravis.

Sampath S, McCann LJ, McDonagh J, Cleary G, Spinty S, Pain CE, Baildam EM, Beresford MW.

Lupus. 2015 Nov;24(13):1462-3. doi: 10.1177/0961203315591030. Epub 2015 Jun 17. No abstract available.

PMID:
26085593
12.

Development of an internationally agreed minimal dataset for juvenile dermatomyositis (JDM) for clinical and research use.

McCann LJ, Kirkham JJ, Wedderburn LR, Pilkington C, Huber AM, Ravelli A, Appelbe D, Williamson PR, Beresford MW.

Trials. 2015 Jun 12;16:268. doi: 10.1186/s13063-015-0784-0.

13.

Analysis of hospital admissions due to accidental non-fire-related carbon monoxide poisoning in England, between 2001 and 2010.

Ghosh RE, Close R, McCann LJ, Crabbe H, Garwood K, Hansell AL, Leonardi G.

J Public Health (Oxf). 2016 Mar;38(1):76-83. doi: 10.1093/pubmed/fdv026. Epub 2015 Mar 9.

14.

Descriptive epidemiology of school outbreaks of seasonal influenza B during 2012/2013 in the Thames Valley, United Kingdom.

McCann LJ, Suchanek O, McCarthy ND, Mannes T.

Public Health. 2014 Dec;128(12):1121-4. doi: 10.1016/j.puhe.2014.08.016. Epub 2014 Nov 25. No abstract available.

PMID:
25443101
15.

Developing a provisional, international minimal dataset for Juvenile Dermatomyositis: for use in clinical practice to inform research.

McCann LJ, Arnold K, Pilkington CA, Huber AM, Ravelli A, Beard L, Beresford MW, Wedderburn LR.

Pediatr Rheumatol Online J. 2014 Jul 21;12:31. doi: 10.1186/1546-0096-12-31. eCollection 2014.

16.

Mucocutaneous manifestations in a UK national cohort of juvenile-onset systemic lupus erythematosus patients.

Chiewchengchol D, Murphy R, Morgan T, Edwards SW, Leone V, Friswell M, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, Wilkinson N, Riley P, Tizard J, Armon K, Sinha MD, Ioannou Y, Mann R, Bailey K, Davidson J, Baildam EM, Pain CE, Cleary G, McCann LJ, Beresford MW; UK JSLE Study Group.

Rheumatology (Oxford). 2014 Aug;53(8):1504-12. doi: 10.1093/rheumatology/keu137. Epub 2014 Mar 31.

PMID:
24692572
17.

Self-reported adverse events in adolescents aged 13-18 years after mass vaccination with pertussis-containing vaccine, following a school outbreak.

McCann LJ, Ford KJ, Pollard AJ, Kulkarni R, Amirthalingam G, Smith A, McCarthy ND.

Public Health. 2013 Dec;127(12):1133-6. doi: 10.1016/j.puhe.2013.09.007. Epub 2013 Nov 22. No abstract available.

PMID:
24275027
18.

Phenotypic variations of cartilage hair hypoplasia: granulomatous skin inflammation and severe T cell immunodeficiency as initial clinical presentation in otherwise well child with short stature.

McCann LJ, McPartland J, Barge D, Strain L, Bourn D, Calonje E, Verbov J, Riordan A, Kokai G, Bacon CM, Wright M, Abinun M.

J Clin Immunol. 2014 Jan;34(1):42-8. doi: 10.1007/s10875-013-9962-6. Epub 2013 Nov 12.

PMID:
24217815
19.

Children and adolescents with SLE: not just little adults.

Morgan TA, Watson L, McCann LJ, Beresford MW.

Lupus. 2013 Oct;22(12):1309-19. doi: 10.1177/0961203313502863.

PMID:
24098003
20.

Indoor carbon monoxide: a case study in England for detection and interventions to reduce population exposure.

McCann LJ, Close R, Staines L, Weaver M, Cutter G, Leonardi GS.

J Environ Public Health. 2013;2013:735952. doi: 10.1155/2013/735952. Epub 2013 Apr 4.

21.

Disease activity, severity, and damage in the UK Juvenile-Onset Systemic Lupus Erythematosus Cohort.

Watson L, Leone V, Pilkington C, Tullus K, Rangaraj S, McDonagh JE, Gardner-Medwin J, Wilkinson N, Riley P, Tizard J, Armon K, Sinha MD, Ioannou Y, Archer N, Bailey K, Davidson J, Baildam EM, Cleary G, McCann LJ, Beresford MW; UK Juvenile-Onset Systemic Lupus Erythematosus Study Group.

Arthritis Rheum. 2012 Jul;64(7):2356-65. doi: 10.1002/art.34410.

22.

The use of transient evoked otoacoustic emissions as a hearing screen following grommet insertion.

Dale OT, McCann LJ, Thio D, Wells SC, Drysdale AJ.

J Laryngol Otol. 2011 Jul;125(7):692-5. doi: 10.1017/S0022215111000570. Epub 2011 Apr 27.

PMID:
21524331
23.

Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations.

Rajab A, Straub V, McCann LJ, Seelow D, Varon R, Barresi R, Schulze A, Lucke B, Lützkendorf S, Karbasiyan M, Bachmann S, Spuler S, Schuelke M.

PLoS Genet. 2010 Mar 12;6(3):e1000874. doi: 10.1371/journal.pgen.1000874.

24.

A randomized comparative trial of generalized vs targeted physiotherapy in the management of childhood hypermobility.

Kemp S, Roberts I, Gamble C, Wilkinson S, Davidson JE, Baildam EM, Cleary AG, McCann LJ, Beresford MW.

Rheumatology (Oxford). 2010 Feb;49(2):315-25. doi: 10.1093/rheumatology/kep362. Epub 2009 Nov 30.

PMID:
19948753
25.

The detection of subclinical synovitis by ultrasound in oligoarticular juvenile idiopathic arthritis: a pilot study.

Haslam KE, McCann LJ, Wyatt S, Wakefield RJ.

Rheumatology (Oxford). 2010 Jan;49(1):123-7. doi: 10.1093/rheumatology/kep339. Epub 2009 Nov 20.

PMID:
19933594
26.

Cardiac disease causing death in a child with Wegener's granulomatosis.

McErlane F, McCann LJ.

J Paediatr Child Health. 2009 Nov;45(11):685-6. doi: 10.1111/j.1440-1754.2009.01622.x. No abstract available.

PMID:
19903254
27.

A retrospective clinical analysis of pharmacological modalities used for symptomatic relief of Raynaud's phenomenon in children treated in a UK paediatric rheumatology centre.

Gargh K, Baildam EM, Cleary GA, Beresford MW, McCann LJ.

Rheumatology (Oxford). 2010 Jan;49(1):193-4. doi: 10.1093/rheumatology/kep309. Epub 2009 Oct 1. No abstract available.

PMID:
19797310
28.

Challenges in the management of juvenile idiopathic arthritis with etanercept.

Pain CE, McCann LJ.

Biologics. 2009;3:127-39. Epub 2009 Jul 13.

29.

Doctors as teachers: what do they think?

McCann LJ, Naden G, Child S.

N Z Med J. 2009 Apr 3;122(1292):16-22.

PMID:
19448770
30.

Effectiveness of infliximab in the treatment of refractory juvenile dermatomyositis with calcinosis.

Riley P, McCann LJ, Maillard SM, Woo P, Murray KJ, Pilkington CA.

Rheumatology (Oxford). 2008 Jun;47(6):877-80. doi: 10.1093/rheumatology/ken074. Epub 2008 Apr 9.

PMID:
18403404
31.

HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.

Wedderburn LR, McHugh NJ, Chinoy H, Cooper RG, Salway F, Ollier WE, McCann LJ, Varsani H, Dunphy J, North J, Davidson JE; Juvenile Dermatomyositis Research Group (JDRG).

Rheumatology (Oxford). 2007 Dec;46(12):1786-91. Epub 2007 Nov 14.

PMID:
18003662
32.

Oropharyngeal dysphagia in juvenile dermatomyositis (JDM): an evaluation of videofluoroscopy swallow study (VFSS) changes in relation to clinical symptoms and objective muscle scores.

McCann LJ, Garay SM, Ryan MM, Harris R, Riley P, Pilkington CA.

Rheumatology (Oxford). 2007 Aug;46(8):1363-6. Epub 2007 Jun 14.

PMID:
17569746
33.

Biologic therapies in juvenile idiopathic arthritis: why and for whom?

McCann LJ, Woo P.

Acta Reumatol Port. 2007 Jan-Mar;32(1):15-26. Review.

34.

Failure to over express MHC-CLASS-1 on muscle biopsy in a case of amyopathic juvenile dermatomyositis.

McCann LJ, Li CK, Varsani H, Wedderburn LR, Pilkington CA.

Clin Exp Rheumatol. 2007 Jan-Feb;25(1):96-8.

PMID:
17417998
35.

Should children under treatment for juvenile idiopathic arthritis receive flu vaccination?

McCann LJ.

Arch Dis Child. 2007 Apr;92(4):366-8. Review. No abstract available.

36.

The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yr.

McCann LJ, Juggins AD, Maillard SM, Wedderburn LR, Davidson JE, Murray KJ, Pilkington CA; Juvenile Dermatomyositis Research Group.

Rheumatology (Oxford). 2006 Oct;45(10):1255-60. Epub 2006 Mar 27.

PMID:
16567354
37.

Macrophage activation syndrome as an early presentation of Lupus.

McCann LJ, Hasson N, Pilkington CA.

J Rheumatol. 2006 Feb;33(2):438-40. No abstract available.

PMID:
16482659
38.

Supplemental Content

Loading ...
Support Center